Methods and compositions using Klotho-FGF fusion polypeptides

Details for Australian Patent Application No. 2009209696 (hide)

Owner Novartis AG

Inventors Glass, David; Hu, Shou-Ih

Agent Davies Collison Cave

Pub. Number AU-B-2009209696

PCT Pub. Number WO2009/095372

Priority 61/063,015 28.01.08 US

Filing date 26 January 2009

Wipo publication date 6 August 2009

Acceptance publication date 19 April 2012

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/095372 Priority application(s): WO2009/095372

19 April 2012 Application Accepted

  Published as AU-B-2009209696

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009209697-Method for coating metal surfaces with a phosphate layer and then with a polymer lubricant layer

2009209695-A charging device for distributing bulk material